Bruno P Imbimbo Selected Research

Metabolic Syndrome (Dysmetabolic Syndrome X)

1/2017

Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruno P Imbimbo Research Topics

Disease

63	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 11/2004
23	Cognitive Dysfunction 01/2022 - 05/2009
13	Dementia (Dementias) 01/2023 - 01/2010
10	Amyloid Plaque 01/2023 - 11/2004
6	Memory Disorders (Memory Loss) 07/2013 - 01/2010
4	Disease Progression 10/2023 - 01/2009
4	Meningoencephalitis 03/2014 - 11/2010
4	Edema (Dropsy) 02/2012 - 11/2010
3	Neuroinflammatory Diseases 01/2021 - 09/2013
2	Tauopathies 01/2022 - 01/2019
2	Inflammation (Inflammations) 01/2021 - 10/2019
2	Frontotemporal Dementia (Semantic Dementia) 01/2019 - 01/2016
2	Hypertension (High Blood Pressure) 01/2017 - 04/2013
2	Neuralgia (Stump Neuralgia) 08/2006 - 05/2005
1	Huntington Disease (Huntington's Disease) 08/2023
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 08/2023
1	Parkinson Disease (Parkinson's Disease) 08/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2023
1	Major Depressive Disorder (Major Depressive Disorders) 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Hallucinations (Hallucination) 02/2021
1	Parkinsonian Disorders (Parkinsonism) 02/2021
1	Dysbiosis 09/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2020
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Amyloidosis 11/2019

Drug/Important Bio-Agent (IBA)

33	Amyloid (Amyloid Fibrils)IBA 05/2024 - 10/2010
17	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2023 - 12/2007
15	Peptides (Polypeptides)IBA 01/2022 - 04/2007
10	Proteins (Proteins, Gene)FDA Link 08/2023 - 10/2010
9	Monoclonal AntibodiesIBA 08/2023 - 11/2010
9	Amyloid beta-PeptidesIBA 01/2010 - 04/2007
8	1- (3',4'- dichloro- 2- fluoro(1,1'- biphenyl)- 4- yl)cyclopropanecarboxylic acidIBA 09/2013 - 12/2007
7	Biomarkers (Surrogate Marker)IBA 04/2024 - 09/2013
7	solanezumabIBA 08/2023 - 02/2012
7	tau Proteins (tau Protein)IBA 01/2022 - 12/2009
7	bapineuzumabIBA 10/2014 - 11/2010
6	EnzymesIBA 08/2023 - 01/2008
6	AntibodiesIBA 01/2023 - 02/2012
5	gantenerumabIBA 08/2023 - 03/2014
5	ApolipoproteinsIBA 09/2020 - 08/2009
5	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2017 - 05/2009
5	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2017 - 05/2009
5	VaccinesIBA 03/2014 - 11/2010
5	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2010 - 11/2004
4	Monounsaturated Fatty AcidsIBA 01/2017 - 01/2010
4	AN-1792IBA 03/2014 - 11/2010
3	crenezumabIBA 08/2023 - 03/2014
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2017 - 01/2010
3	Apolipoproteins E (ApoE)IBA 02/2012 - 01/2010
2	Investigational DrugsIBA 08/2023 - 12/2021
2	lecanemabIBA 04/2023 - 01/2023
2	Cholinergic Agents (Cholinergics)IBA 01/2021 - 12/2016
2	Glucose (Dextrose)FDA LinkGeneric 09/2020 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 02/2010
2	Prealbumin (Transthyretin)IBA 11/2019 - 01/2018
2	N-Methylaspartate (NMDA)IBA 10/2019 - 05/2005
2	hydromethylthionineIBA 01/2016 - 01/2016
2	Humanized Monoclonal AntibodiesIBA 10/2014 - 09/2014
2	N2- ((2S)- 2- (3,5- difluorophenyl)- 2- hydroxyethanoyl)- N1- ((7S)- 5- methyl- 6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- L- alaninamideIBA 01/2010 - 07/2009
2	Naproxen (Naprosyn)FDA LinkGeneric 01/2010 - 08/2009
2	rofecoxib (Vioxx)FDA Link 01/2010 - 08/2009
2	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 01/2010 - 01/2009
2	Neurotransmitter Agents (Neurotransmitter)IBA 12/2009 - 11/2009
2	Monoamine Oxidase (MAO)IBA 08/2006 - 05/2005
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 08/2023
1	Glucosylceramidase (Glucocerebrosidase)IBA 08/2023
1	Presenilin-1IBA 08/2023
1	venglustatIBA 08/2023
1	tominersenIBA 08/2023
1	tofersenIBA 08/2023
1	ceramide glucosyltransferaseIBA 08/2023
1	Presenilin-2IBA 08/2023
1	Antisense OligonucleotidesIBA 08/2023
1	Superoxide Dismutase-1IBA 08/2023
1	Huntingtin ProteinIBA 08/2023
1	aducanumabIBA 01/2023
1	donanemabIBA 01/2023
1	SulfonamidesIBA 02/2021
1	Zonisamide (Zonegran)FDA LinkGeneric 02/2021
1	PresenilinsIBA 02/2021
1	Levodopa (L Dopa)FDA LinkGeneric 02/2021
1	APTIBA 02/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 02/2021
1	Complement C3 (C3 Complement)IBA 01/2021
1	CytokinesIBA 01/2021
1	LigandsIBA 01/2020
1	RNA-Binding Protein FUSIBA 01/2020
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2020
1	TATA-Box Binding Protein (TATA-Binding Protein)IBA 01/2020

Therapy/Procedure

16	Therapeutics 10/2023 - 01/2008
10	Immunotherapy 01/2019 - 04/2007
3	Secondary Prevention 01/2018 - 08/2009
2	Plasma Exchange 09/2020 - 01/2020
2	Institutionalization (Institutionalized Persons) 03/2013 - 01/2011
2	Mediterranean Diet 05/2011 - 01/2010
1	Investigational Therapies (Experimental Therapy) 08/2023
1	Immunomodulation 09/2020
1	Precision Medicine 01/2020